Global Financial Private Client, LLC Bristol Myers Squibb CO Transaction History

Global Financial Private Client, LLC

$262 Billion
Q1 2025

A detailed history of Global Financial Private Client, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Global Financial Private Client, LLC holds 2,736 shares of BMY stock, worth $131,574. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,736

Previous 2,634 3.87%

Holding current value

$131,574

Previous $149 Million 12.01%

% of portfolio

0.06%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 07, 2025	BUY	$53.9 - $63.11 $5,497 - $6,437	102 Added 3.87%	2,736 $167 Million
Q4 2024 Jan 13, 2025	BUY	$51.92 - $59.94 $2,284 - $2,637	44 Added 1.7%	2,634 $149 Million
Q3 2024 Oct 07, 2024	BUY	$39.66 - $51.75 $40,929 - $53,406	1,032 Added 66.24%	2,590 $134 Million
Q2 2024 Jul 29, 2024	SELL	$40.25 - $52.99 $36,225 - $47,691	-900 Reduced 36.62%	1,558 $64.7 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $2,303 - $2,611	-48 Reduced 1.92%	2,458 $130 Million
Q3 2023 May 15, 2024	SELL	$57.89 - $64.73 $3,589 - $4,013	-62 Reduced 2.41%	2,506 $145 Million
Q2 2023 May 15, 2024	SELL	$63.71 - $70.74 $19,176 - $21,292	-301 Reduced 10.49%	2,568 $165 Million
Q1 2023 May 15, 2024	SELL	$65.71 - $74.53 $2,102 - $2,384	-32 Reduced 1.1%	2,869 $200 Million
Q4 2022 May 15, 2024	BUY	$68.48 - $81.09 $26,570 - $31,462	388 Added 15.44%	2,901 $209 Million
Q3 2022 May 15, 2024	SELL	$0.13 - $76.84 $14 - $8,298	-108 Reduced 4.12%	2,513 $177 Million
Q2 2022 May 15, 2024	BUY	$72.62 - $79.98 $11,473 - $12,636	158 Added 6.41%	2,621 $201 Million
Q1 2022 May 15, 2024	SELL	$61.48 - $73.72 $11,619 - $13,933	-189 Reduced 7.13%	2,463 $182 Million
Q4 2021 May 15, 2024	SELL	$53.63 - $62.52 $434,456 - $506,474	-8,101 Reduced 75.34%	2,652 $165 Million
Q3 2021 May 15, 2024	BUY	$59.17 - $69.31 $30,472 - $35,694	515 Added 5.03%	10,753 $640 Million
Q2 2021 May 15, 2024	BUY	$61.91 - $67.42 $227,581 - $247,835	3,676 Added 56.02%	10,238 $681 Million
Q1 2021 May 15, 2024	BUY	$59.34 - $66.74 $32,458 - $36,506	547 Added 9.09%	6,562 $413 Million
Q4 2020 May 15, 2024	SELL	$57.74 - $65.43 $24,712 - $28,004	-428 Reduced 6.64%	6,015 $373 Million
Q3 2020 May 15, 2024	BUY	$57.43 - $63.64 $27,796 - $30,801	484 Added 8.12%	6,443 $385 Million
Q2 2020 May 15, 2024	BUY	$54.82 - $64.09 $27,410 - $32,045	500 Added 9.16%	5,959 $354 Million
Q1 2020 May 15, 2024	BUY	$46.4 - $67.43 $180,264 - $261,965	3,885 Added 246.82%	5,459 $299 Million
Q4 2019 May 15, 2024	BUY	$49.21 - $64.19 $77,456 - $101,035	1,574 New	1,574 $101 Million

Others Institutions Holding BMY

# of Institutions

2,809

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $102B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.

Account

Global Financial Private Client, LLC Bristol Myers Squibb CO Transaction History